Modelling ponatinib resistance in tyrosine kinase inhibitor-naïve and dasatinib resistant BCR-ABL1+ cell lines
在酪氨酸激酶抑制剂初治和达沙替尼耐药的 BCR-ABL1+ 细胞系中模拟普纳替尼耐药性
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.26187
Liu Lu, Chung Hoow Kok, Verity Ann Saunders, Jueqiong Wang, Jennifer Anne McLean, Timothy Peter Hughes, Deborah Lee White